Our findings regarding live-attenuated Rev-Ind Nef ̄SIV as well as examples from the literature demonstrate that inflammation or immune activation at acute stages of infection, be it with a live-attenuated vaccine strain, HSV-2, or parasites increase host susceptibility to de novo HIV/SHIV infection. This evidence concerns the gene S100B and infection.